Skip to main content
. 2023 Jun 20;67(2):3667. doi: 10.4081/ejh.2023.3667

Figure 1.

Figure 1.

LncRNA FBXO18-AS is expressed at higher levels in gastric cancer and linked to poor outcomes in patients. a,b) TCGA database showed that gastric cancer FBXO18-AS expression was upregulated in comparison to the normal control (p<0.001, Student's t-test). c) ROC dissection of FBXO18-AS in gastric cancers according to the TCGA database. d) Kaplan-Meier analysis indicated the predictive significance of low FBXO18-AS expression vs high FBXO18-AS expression in gastric cancer patients in the TCGA database (p=0.013). e) qPCR illustrated that FBXO18-AS expression was increased in gastric cancer cells compared to normal control cells (p<0.001, Student's t-test). f ) Kaplan-Meier analysis showed the predictive significance of higher FBXO18-AS expression versus lower FBXO18-AS expression in 40 gastric cancer patients as determined by qPCR (p=0.0081; log-rank test). The overall data are presented as the mean ± SD (three independent tests); ***p<0.001; **p<0.01; *p<0.05.